SUBSCRIBE
SUBSCRIBE

Shuttle Pharmaceuticals

IN THE PRESS
Press Releases
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
June 13, 2025
 · 
3 min read
Press Releases
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time
June 13, 2025
 · 
3 min read
Press Releases
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors
June 5, 2025
 · 
3 min read
Press Releases
Shuttle Pharma Provides Corporate Update
May 15, 2025
 · 
5 min read
Press Releases
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial
May 9, 2025
 · 
4 min read
Press Releases
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
April 22, 2025
 · 
3 min read
Press Releases
Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
April 11, 2025
 · 
6 min read
Press Releases
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
March 14, 2025
 · 
4 min read
Press Releases
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
March 13, 2025
 · 
4 min read
Press Releases
Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities
March 12, 2025
 · 
4 min read
Load More
JOBS